Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin degludec versus insulin detemir, both with insulin aspart, in pregnant women with type 1 diabetes
MOH_2017-11-08_000577Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Aug 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of insulin degludec, insulin detemir and insulin aspart in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Novo Nordisk. Started Aug 2017; status: completed.
02
Drugs
insulin degludecinsulin detemirinsulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on MOH_2017-11-08_000577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-11-08_000577.